This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kiira Ratia: Innovator in Biochemical Compounds
Introduction
Kiira Ratia is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that enhance the levels of nicotinamide adenine dinucleotide (NAD) in subjects. Her work has implications for treating various neurodegenerative diseases.
Latest Patents
Kiira Ratia holds a patent for "Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof." This patent focuses on compounds that can raise the amount of NAD in a subject, which may help in treating or preventing diseases associated with reduced levels of this important coenzyme. By increasing NAD levels, symptoms of conditions such as Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, AIDS-induced dementia, and epilepsy can potentially be reduced or ameliorated.
Career Highlights
Kiira Ratia is affiliated with the University of Illinois, where she continues her research and development in biochemistry. Her innovative work has garnered attention in the scientific community, contributing to advancements in health and medicine.
Collaborations
Some of her notable coworkers include Tom G Driver and Gregory R Thatcher, who collaborate with her on various research projects.
Conclusion
Kiira Ratia's contributions to the field of biochemistry through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds the potential to improve the quality of life for individuals suffering from serious health conditions.